title: [Myocardial infarct in diabetes mellitus patients. A long-term follow-up].
abstract: The acute phase and long-term evolution of 249 patients diagnosed as having acute myocardial infarction and admitted to our hospital during the period 1981 to 1983, were studied. They were classified in 2 groups: A (non-diabetic patients) and B (diabetic patients). Several variables were analysed in order to determine the differences between both groups. The most accentuated being: diabetic patients, female sex, old age, blood hypertension history, cardiac failure, re-extended infarction. The inter-hospital mortality was higher in group B, mainly as a result of cardiogenic shock and left cardiac failure. An out-patients follow-up of acute phase survivors was carried out, between 1 to 96 months, with mean follow-up of 46.7 month in group A and 38.4 in group B, at 8 years the actuarial rate being 77.3% and 55.9% respectively. We conclude that diabetic patients with myocardial infarction register a higher long- and short-time mortality.
authors.affiliation: Unidad de Cardiología, Hospital del INSALUD, Talavera de la Reina, Toledo.
authors.forename: C
authors.initials: C
authors.lastname: Hernández Lanchas
authors.forename: P
authors.initials: P
authors.lastname: Parrilla Herranz
authors.forename: P
authors.initials: P
authors.lastname: Llorente Domingo
authors.forename: J C
authors.initials: JC
authors.lastname: Aparicio Martínez
authors.forename: M J
authors.initials: MJ
authors.lastname: Arranz Nieto
authors.forename: A
authors.initials: A
authors.lastname: Durán Pérez-Navarro
mesh_terms: D000206:Actuarial Analysis; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology* / Q000401:mortality; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology* / Q000401:mortality; D005500:Follow-Up Studies; D006801:Humans; D009203:Myocardial Infarction / Q000453:epidemiology* / Q000401:mortality; D013030:Spain / Q000453:epidemiology; D016019:Survival Analysis; D013997:Time Factors
vernacular_title: Infarto de miocardio en pacientes con diabetes mellitus. Seguimiento a largo plazo.